Gastrointestinal
Boston Scientific to acquire Apollo Endosurgery for $615m
The deal is intended to expand Boston Scientific’s endoluminal surgery portfolio.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox